|
|
|
Volumn 2, Issue 2, 1999, Pages 47-52
|
|
Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPRAZOLAM;
ANTIFUNGAL AGENT;
CYCLOSPORIN;
CYP3A PROTEIN, HUMAN;
CYTOCHROME P450;
ENZYME INHIBITOR;
KETOCONAZOLE;
MIXED FUNCTION OXIDASE;
TACROLIMUS;
TRIAZOLAM;
AREA UNDER THE CURVE;
ARTICLE;
BINDING COMPETITION;
BIOAVAILABILITY;
BODY FLUID COMPARTMENT;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG INTERACTION;
ENZYMOLOGY;
HUMAN;
KINETICS;
LIVER;
METABOLISM;
ALPRAZOLAM;
ANTIFUNGAL AGENTS;
AREA UNDER CURVE;
BINDING, COMPETITIVE;
BIOLOGICAL AVAILABILITY;
BODY FLUID COMPARTMENTS;
CYCLOSPORINE;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG INTERACTIONS;
ENZYME INHIBITORS;
HUMANS;
KETOCONAZOLE;
KINETICS;
LIVER;
MIXED FUNCTION OXYGENASES;
TACROLIMUS;
TRIAZOLAM;
|
|
EID: 0033123238
PISSN: None
EISSN: 14821826
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (65)
|
|
References (0)
|
